- Abstract
1- 10.1016/j.annonc.2021.08.1389
1005P A new platform of personalized neoantigen cancer vaccines directed by checkpoint inhibitor antibodies to improve cancer immunity
- Sep 01, 2021
- Annals of Oncology
- Y Mishima + 9 more +9
BrightPath Biotherapeutics (Japan)
Recent publications and citations
Top Concepts
Top subject area publications in last 5 years
Collaboration Analysis
Publications from 2021 to 2026
Latest Publications
Filter 